The Recall Desk

Hazard

Particulate Matter recalls

410 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.

What the numbers show

Total
410
Critical
57
Severe
186
Most recent
2026-09-02

Of the 410 particulate matter recalls we have scored against our rubric, 57 (14%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 186 (45%) are Severe.

Which agencies issued them

About this hazard tag

Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all particulate matter recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.

A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.

326–350 of 410

  • CriticalFDA (Drugs)·D-1595-2014·2014-09-24

    Bristol-Myers Squibb Recalls Coumadin for Injection Due to Particulate Matter

    Bristol-Myers Squibb is recalling Coumadin for Injection vials because metallic-like and cellulose fiber particles were found in retained samples.

    Product
    COUMADIN FOR INJECTION (Warfarin Sodium for Injection, USP 5 mg Single-Use Vial Rx Only Distributed by Bristol Meyers Squibb Company, Princeton, NJ 08543 USA NDC 0590-0324-96
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-1592-2014·2014-09-24

    Baxter Recalls Sodium Chloride Injection Bags Due to Particulate Matter

    Baxter Healthcare is recalling 390,560 bags of 0.9% Sodium Chloride Injection USP due to the presence of particulate matter, including fibers and plastics.

    Product
    SODIUM CHLORIDE — SODIUM CHLORIDE (SODIUM CHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-1591-2014·2014-09-24

    Baxter Recalls Sodium Chloride Injection Bags Due to Particulate Matter

    Baxter Healthcare is recalling specific lots of 0.9% Sodium Chloride Injection USP bags due to the presence of particulate matter, including fibers and plastics.

    Product
    SODIUM CHLORIDE — SODIUM CHLORIDE (SODIUM CHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1593-2014·2014-09-24

    Baxter Recalls Potassium Chloride Injection Due to Particulate Matter

    Baxter Healthcare is recalling 171,672 bags of Potassium Chloride Injection due to the presence of particulate matter, including fibers and plastics.

    Product
    POTASSIUM CHLORIDE — POTASSIUM CHLORIDE (POTASSIUM CHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-1588-2014·2014-09-24

    Hospira Recalls Bupivacaine Hydrochloride Vials Due to Particulate Matter

    Hospira Inc. is recalling 75,000 vials of Bupivacaine Hydrochloride 0.5% due to a confirmed report of a brown, rust-colored particle embedded in the glass vial.

    Product
    BUPIVACAINE HYDROCHLORIDE — BUPIVACAINE HYDROCHLORIDE (BUPIVACAINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-1550-2014·2014-08-27

    Baxter Recalls 0.9% Sodium Chloride Injection Due to Particulate Matter

    Baxter Healthcare is recalling 4,200 containers of 0.9% Sodium Chloride Injection because blue polyisoprene shavings were found inside the bag port tubes.

    Product
    0.9 % Sodium Chloride Injection, USP, 1000 mL in VIAFLEX Plastic Container, Baxter Healthcare Corporation, Deerfield, IL 60015
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1547-2014·2014-08-27

    Hospira Recalls Propofol Vials Due to Metallic Particulate Matter

    Hospira Inc. is recalling 844,300 vials of Propofol Injectable Emulsion because glass defects allowed metallic particulates to enter the solution.

    Product
    PROPOFOL — PROPOFOL (PROPOFOL)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-1542-2014·2014-08-27

    Baxter Recalls ProSol Amino Acid Injection Due to Particulate Matter

    Baxter Healthcare is recalling 6,204 bags of ProSol Amino Acid Injection because a retention sample contained particulate matter. The product was distributed nationwide.

    Product
    PROSOL — PROSOL (VALINE, LYSINE, HISTIDINE, ISOLEUCINE, LEUCINE, PHENYLALANINE, THREONINE, METHIONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1512-2014·2014-08-13

    Alexion Recalls Soliris Vials Due to Visible Particulate Matter

    Alexion Pharmaceuticals is recalling 96,506 vials of Soliris (eculizumab) because the product failed appearance tests for visible particles under labeled storage conditions.

    Product
    SOLIRIS — SOLIRIS (ECULIZUMAB)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1424-2014·2014-07-16

    Hospira Recalls Labetalol Hydrochloride Injection Due to Particulate Matter

    Hospira Inc. is recalling Labetalol Hydrochloride Injection due to the presence of particulate matter, including metal embedded in glass vials and visible particles in the solution.

    Product
    LABETALOL HYDROCHLORIDE — LABETALOL HYDROCHLORIDE (LABETALOL HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1422-2014·2014-07-16

    Healix Recalls Bupivacaine HCl Bags Due to Particulate Matter

    Healix Infusion Therapy is recalling 10 bags of BUPivacaine HCl 0.25% in On-Q C-bloc bags distributed in Texas due to visible particles.

    Product
    BUPivacaine HCl 0.25% Preservative Free (2.5 mg/mL) 500 mL in On-Q C-bloc (2-14 mL/hr) bag, Healix Infusion Therapy, Inc., 1075 West Park One Drive, Suite 200, Sugar Land, Texas 77478, NDC 75901-7210-53.
    Category
    Drug
    Distribution
    1 state
  • ModerateFDA (Drugs)·D-1413-2014·2014-07-09

    Baxter Recalls Brevibloc Injection Due to Particulate Matter

    Baxter Healthcare is recalling Brevibloc (esmolol hydrochloride) injection due to complaints of discolored solution and subvisible iron oxide particles.

    Product
    BREVIBLOC — BREVIBLOC (ESMOLOL HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1382-2014·2014-06-18

    Cubist Recalls CUBICIN Vials Due to Glass Shard Presence

    Cubist Pharmaceuticals is recalling 51,500 vials of CUBICIN (daptomycin) because a customer reported a glass shard in one vial.

    Product
    CUBICIN (daptomycin for injection), 500 mg single-use vial, Rx only, Manufactured for: Cubist Pharmaceuticals, Inc., Lexington, MA 02421, NDC 67919-011-01, UPC 3 67919-011-01 6.
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-1358-2014·2014-06-11

    Hospira Recalls Marcaine Injection Vials Due to Visible Metal Particles

    Hospira is recalling 85,680 vials of Marcaine (bupivacaine HCl) injection because a customer complaint confirmed the presence of visible metal particles and discolored solution.

    Product
    MARCAINE — MARCAINE (BUPIVACAINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-1273-2014·2014-05-07

    B. Braun Recalls TrophAmine Injection Due to Particulate Matter

    B. Braun Medical Inc. is recalling TrophAmine (10% Amino Acid Injection) units due to visible particulate matter found in reserve samples.

    Product
    TrophAmine (10% Amino Acid Injection), 500 mL Container, Rx Only, Catalog No. S9341-SS, Sterile, Single Dose Container, B Braun Medical Inc., Irvine CA 92614-5895, NDC 0264-9341-55
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-1269-2014·2014-05-07

    B. Braun Recalls Cefazolin Sodium Injectable Due to Particulate Matter

    B. Braun Medical Inc. is recalling Cefazolin Sodium injectable products because visible particulate matter was found in reserve sample units.

    Product
    CEFAZOLIN SODIUM — CEFAZOLIN SODIUM (CEFAZOLIN SODIUM)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1272-2014·2014-05-07

    B. Braun Recalls 15% Amino Acids Injection Due to Particulate Matter

    B. Braun Medical Inc. is recalling 15% Amino Acids Injection products due to visible particulate matter found in reserve sample units.

    Product
    15% Amino Acids Injection PBP Glass, 1000 mL, Catalog No. S3200-SS, Pharmacy Bulk Package, Not For Direct Infusion, For Intravenous Use, Sterile, Single Dose Container, Rx Only, B Braun Medical Inc., Irvine, CA 92614-5895, NDC 0264-3200-55
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1274-2014·2014-05-07

    B. Braun Recalls ProcalAmine Injectable Due to Particulate Matter

    B. Braun Medical Inc. is recalling ProcalAmine injectable products due to visible particulate matter found in reserve samples.

    Product
    ProcalAmine (3% Amino Acid and 3% Glycerin Injection with Electrolytes) 1000 mL Container, Rx Only, Catalog No. S9050, Sterile, Single Dose Container, B Braun Medical Inc., Irvine CA 92614-5895, NDC 0264-1915-07
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1271-2014·2014-05-07

    B. Braun Recalls FreAmine HBC Injection Due to Particulate Matter

    B. Braun Medical Inc. is recalling 6.9% FreAmine HBC (Amino Acid Injection) units due to visible particulate matter found in reserve samples.

    Product
    6.9% FreAmine HBC (Amino Acid Injection), partial fill container 750 mL in a 1000 mL container, Catalog No. S9350-58SS, Sterile, Single dose container, Rx Only, B Braun Medical Inc., Irvine, CA 92614-5895, NDC 0264-9350-55
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1270-2014·2014-05-07

    B. Braun Recalls Sodium Chloride Injection Due to Particulate Matter

    B. Braun Medical Inc. is recalling 0.9% Sodium Chloride Injection USP due to visible particulate matter found in reserve samples.

    Product
    0.9 % Sodium Chloride Injection USP, 1000 mL, Catalog No. S4000-SS, Rx Only, Sterile, Single Dose Container, B Braun Medical Inc., Irvine, CA 92614-5895, NDC 0264-4000-55
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1267-2014·2014-05-07

    B. Braun Recalls Cefepime Injection Due to Visible Particulate Matter

    B. Braun Medical Inc. is recalling Cefepime Hydrochloride and Dextrose injection units because visible particulate matter was found in reserve samples.

    Product
    CEFEPIME HYDROCHLORIDE AND DEXTROSE — CEFEPIME HYDROCHLORIDE AND DEXTROSE (CEFEPIME HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1268-2014·2014-05-07

    B. Braun Recalls Cefazolin Sodium Injectable Due to Particulate Matter

    B. Braun Medical Inc. is recalling specific lots of Cefazolin Sodium injectable products because visible particulate matter was found in reserve sample units.

    Product
    CEFAZOLIN SODIUM — CEFAZOLIN SODIUM (CEFAZOLIN SODIUM)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1260-2014·2014-05-07

    John W Hollis Inc Recalls Polidocanol 3% Solution Due to Particulate Matter

    John W Hollis Inc is recalling 3 vials of Polidocanol 3% Solution due to the presence of particulate matter. The product was distributed in Missouri, Tennessee, Mississippi, and Wisconsin.

    Product
    Polidocanol 3% Solution, 50 mL Vial, Rx Only, Not for Resale. John Hollis Pharmacy, 110 20th Avenue N, Nashville, TN 37203.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-1265-2014·2014-05-07

    B. Braun Recalls Sodium Chloride Injection Due to Particulate Matter

    B. Braun Medical Inc. is recalling 0.9% Sodium Chloride Injection USP due to visible particulate matter found in reserve sample units.

    Product
    SODIUM CHLORIDE — SODIUM CHLORIDE (SODIUM CHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1275-2014·2014-05-07

    B. Braun Recalls Hyperlyte CR Injectable Due to Particulate Matter

    B. Braun Medical Inc. is recalling Hyperlyte CR injectable products because visible particulate matter was found in reserve sample units.

    Product
    Hyperlyte CR (Multi-Electrolyte Concentrate), 20 mL/dose, 250 mL Container, Catalog No. S9432, Rx Only, Sterile, B Braun Medical Inc., Irvine CA 92614-5895, In Canada Dist by: B Braun Medical Inc., Scarborough, Ontario M1H 2W4, NDC 0264-1943-20, Canada DIN 01924311
    Category
    Drug
    Distribution
    Distributed nationwide